Pfam Domains GO Terms
| Ank |
| Ank 2 |
| positive regulation of myosin-light-chain-phosphatase activity |
| contractile fiber |
| PTW/PP1 phosphatase complex |
| regulation of myosin-light-chain-phosphatase activity |
| phosphatase regulator activity |
| A band |
| regulation of endothelial cell development |
| regulation of establishment of endothelial barrier |
| positive regulation of phosphoprotein phosphatase activity |
| 14-3-3 protein binding |
| enzyme inhibitor activity |
| regulation of endothelial cell differentiation |
| positive regulation of phosphatase activity |
| positive regulation of protein dephosphorylation |
| positive regulation of dephosphorylation |
| centrosome cycle |
| kinetochore |
| microtubule organizing center organization |
| regulation of nucleocytoplasmic transport |
| regulation of phosphoprotein phosphatase activity |
| G2/M transition of mitotic cell cycle |
| Z disc |
| cell cycle G2/M phase transition |
| regulation of protein dephosphorylation |
| regulation of epithelial cell differentiation |
| regulation of phosphatase activity |
| regulation of dephosphorylation |
| protein dephosphorylation |
| actin cytoskeleton |
| mitotic cell cycle phase transition |
| cell cycle phase transition |
| dephosphorylation |
| regulation of intracellular transport |
| cellular response to drug |
| focal adhesion |
| protein kinase binding |
| microtubule cytoskeleton organization |
| centrosome |
| mitotic cell cycle process |
| microtubule-based process |
| regulation of cell adhesion |
| mitotic cell cycle |
| positive regulation of hydrolase activity |
| negative regulation of catalytic activity |
| regulation of cellular localization |
| regulation of cell development |
| cell cycle process |
| response to drug |
| cytoskeleton organization |
| positive regulation of phosphate metabolic process |
| positive regulation of phosphorus metabolic process |
| negative regulation of molecular function |
| positive regulation of transcription by RNA polymerase II |
| positive regulation of protein modification process |
| regulation of hydrolase activity |
| cell cycle |
| positive regulation of catalytic activity |
| positive regulation of transcription, DNA-templated |
| positive regulation of cellular protein metabolic process |
| positive regulation of nucleic acid-templated transcription |
| positive regulation of RNA biosynthetic process |
| positive regulation of protein metabolic process |
| positive regulation of RNA metabolic process |
| positive regulation of molecular function |
| regulation of phosphate metabolic process |
| regulation of phosphorus metabolic process |
| regulation of cell differentiation |
| regulation of protein modification process |
| regulation of transport |
| positive regulation of nucleobase-containing compound metabolic process |
| positive regulation of macromolecule biosynthetic process |
| positive regulation of cellular biosynthetic process |
| positive regulation of gene expression |
| positive regulation of biosynthetic process |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 1/1 |
| 909776.0 | 1/1 |
| bile duct | 25/28 |
| blood | 14/28 |
| bone | 18/26 |
| breast | 22/33 |
| central nervous system | 45/56 |
| cervix | 4/4 |
| colorectal | 16/17 |
| esophagus | 12/13 |
| fibroblast | 1/1 |
| gastric | 15/16 |
| kidney | 15/21 |
| liver | 11/20 |
| lung | 50/75 |
| lymphocyte | 9/16 |
| ovary | 21/26 |
| pancreas | 17/24 |
| peripheral nervous system | 6/16 |
| plasma cell | 8/15 |
| prostate | 0/1 |
| skin | 13/24 |
| soft tissue | 9/9 |
| thyroid | 2/2 |
| upper aerodigestive | 20/22 |
| urinary tract | 24/29 |
| uterus | 4/5 |
Expression Distribution